ICMR Bolsters ‘mid-August’ Covid Vaccine

The Indian Council of Medical Research has shortlisted 12 institutes, including one from Odisha, for human clinical trial of the India’s first COVID-19 vaccine.

ICMR has developed the indigenous BBV152 COVID vaccine in partnership with Bharat Biotech International Limited (BBIL). The apex body selected 12 institutes to fast track clinical trials of the vaccine which is one of the top priority projects monitored by the Central government.

“The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the pre-clinical as well as clinical development of this vaccine,” an official said.

Leave a Reply

Your email address will not be published. Required fields are marked *